Univest
Univest
  • Markets

Yatharth Hospital and Trauma Care Services Analyst Review May 2026

  • May 19, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Yatharth Hospital and Trauma Care Services Analyst Review

This Yatharth Hospital and Trauma Care Services analyst review for May 2026 covers the key data investors need for YATHARTH at its current price of Rs 802.75. Yatharth Hospital and Trauma Care Services (NSE: YATHARTH) is a fast-growing hospital chain in the Delhi NCR region with a market capitalisation of approximately Rs 3,500 crore. The analyst consensus target of Rs 700 implies meaningful upside, and this Yatharth Hospital and Trauma Care Services analyst review examines technical levels, business segments, valuation, and key risks for YATHARTH through FY27.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Yatharth Hospital and Trauma Care Services Company Snapshot May 2026
  • Analyst Insight in This Yatharth Hospital and Trauma Care Services Analyst Review
  • Technical Analysis in This Yatharth Hospital and Trauma Care Services Analyst Review
  • Key Support and Resistance Levels
  • Business Segment Analysis
    • Multi-Specialty Hospitals (Delhi NCR Focus)
    • Trauma and Orthopaedic Services
    • Oncology and Cardiac Care
  • Valuation in This Yatharth Hospital and Trauma Care Services Analyst Review
  • Trade Outlook for Yatharth Hospital and Trauma Care Services
  • Key Risks for Yatharth Hospital and Trauma Care Services in FY27
  • Conclusion: Yatharth Hospital and Trauma Care Services Analyst Review Verdict for 2026
  • Frequently Asked Questions: Yatharth Hospital and Trauma Care Services Analyst Review 2026
    • What is the analyst target for Yatharth Hospital and Trauma Care Services in 2026?
    • Is Yatharth Hospital and Trauma Care Services a good investment at Rs 802.75?
    • What is Yatharth Hospital and Trauma Care Services’s 52-week high and low?
    • What are the key risks for Yatharth Hospital and Trauma Care Services?
    • Where can I track live data for Yatharth Hospital and Trauma Care Services?

Yatharth Hospital and Trauma Care Services Company Snapshot May 2026

Yatharth Hospital operates multi-specialty hospitals in Noida, Greater Noida, and Delhi with a focus on trauma, orthopaedics, oncology, and cardiac services. The company is expanding through brownfield capacity addition and new greenfield hospitals. The table below summarises the key data referenced in this Yatharth Hospital and Trauma Care Services analyst review.

Parameter Value
NSE Ticker YATHARTH
Sector Healthcare – Hospitals
CMP (May 2026) Rs 802.75
52 Week High Rs 887.85
52 Week Low Rs 485.00
Market Cap Rs 3,500 Crore
Trailing P/E 45x
Analyst Consensus Target Rs 700
Bull Case Target Rs 950
Bear Case Target Rs 500

Analyst Insight in This Yatharth Hospital and Trauma Care Services Analyst Review

Associate Director Kunal Singla suggests watching Yatharth Hospital and Trauma Care Services closely in May 2026. At Rs 802.75, Kunal Singla flags Healthcare – Hospitals sector dynamics as the primary driver for YATHARTH’s near-term price action. He notes support in the Rs 495 to Rs 763 zone and flags any sustained close above Rs 851 as a positive signal. Kunal Singla’s perspective on Yatharth Hospital and Trauma Care Services adds professional analysis to this Yatharth Hospital and Trauma Care Services analyst review and is not a buy recommendation.

Technical Analysis in This Yatharth Hospital and Trauma Care Services Analyst Review

At Rs 802.75, YATHARTH is trading within its 52-week band of Rs 485.00 to Rs 887.85. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.

Near-term support is identified in the Rs 495 to Rs 763 band while resistance is seen in the Rs 851 to Rs 751 zone. A sustained move above Rs 851 could open the path toward the analyst consensus target of Rs 700 as outlined in this Yatharth Hospital and Trauma Care Services analyst review.

Screen the best stocks on the Univest Screener.

Key Support and Resistance Levels

  • Support Zone: Rs 495 to Rs 763 – investors tracking this Yatharth Hospital and Trauma Care Services analyst review should watch for stabilisation or a bounce in this range as a potential accumulation signal for YATHARTH.
  • Resistance Zone: Rs 851 to Rs 751 – a sustained close above Rs 851 would be a positive breakout signal worth flagging in this Yatharth Hospital and Trauma Care Services analyst review.
  • Medium-Term Target: The analyst consensus of Rs 700 represents the base-case upside scenario in this Yatharth Hospital and Trauma Care Services analyst review.

Business Segment Analysis

Multi-Specialty Hospitals (Delhi NCR Focus)

This is the primary revenue and margin driver for Yatharth Hospital and Trauma Care Services, directly supporting the earnings trajectory toward the consensus target of Rs 700.

Trauma and Orthopaedic Services

This segment adds scale and diversification to Yatharth Hospital and Trauma Care Services’s business model and is a meaningful EPS contributor through FY27 and FY28.

Oncology and Cardiac Care

This represents the medium-term growth frontier for Yatharth Hospital and Trauma Care Services and a key re-rating catalyst over the next 12 to 24 months.

Valuation in This Yatharth Hospital and Trauma Care Services Analyst Review

At Rs 802.75, Yatharth Hospital and Trauma Care Services trades at a trailing P/E of 45x. This Yatharth Hospital and Trauma Care Services analyst review presents three scenarios: a bull case of Rs 950 on strong earnings delivery and sector tailwinds, a base case of Rs 700 at analyst consensus, and a bear case of Rs 500 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this Yatharth Hospital and Trauma Care Services analyst review.

Scenario Target Price Key Condition
Bull Case Rs 950 Strong earnings delivery and sector re-rating
Base Case (Consensus) Rs 700 Moderate growth, analyst consensus estimate
Bear Case Rs 500 Earnings miss or macro headwinds

Trade Outlook for Yatharth Hospital and Trauma Care Services

Based on the technical and fundamental analysis in this Yatharth Hospital and Trauma Care Services analyst review, investors might watch YATHARTH near the support zone of Rs 495 to Rs 763 for potential opportunities. A flag above Rs 851 could suggest improving momentum toward Rs 700. This article uses watch-and-flag language only and does not constitute a trade recommendation.

Key Risks for Yatharth Hospital and Trauma Care Services in FY27

A well-rounded Yatharth Hospital and Trauma Care Services analyst review must assess downside risks. Key risks for Yatharth Hospital and Trauma Care Services include a macro slowdown affecting Healthcare – Hospitals sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in YATHARTH.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Conclusion: Yatharth Hospital and Trauma Care Services Analyst Review Verdict for 2026

This Yatharth Hospital and Trauma Care Services analyst review concludes that at Rs 802.75, YATHARTH offers a defined risk-reward with a consensus target of Rs 700. The 52-week range of Rs 485.00 to Rs 887.85 provides context on the current entry point. Use this Yatharth Hospital and Trauma Care Services analyst review as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on YATHARTH.

Frequently Asked Questions: Yatharth Hospital and Trauma Care Services Analyst Review 2026

What is the analyst target for Yatharth Hospital and Trauma Care Services in 2026?

The analyst consensus target is Rs 700, with a bull case of Rs 950 and a bear case of Rs 500. This Yatharth Hospital and Trauma Care Services analyst review recommends monitoring Q1 FY27 earnings for confirmation.

Is Yatharth Hospital and Trauma Care Services a good investment at Rs 802.75?

At Rs 802.75 with a P/E of 45x and a consensus target of Rs 700, this Yatharth Hospital and Trauma Care Services analyst review is constructive for medium to long-term investors in the Healthcare – Hospitals sector. Always consult a SEBI-registered advisor before investing.

What is Yatharth Hospital and Trauma Care Services’s 52-week high and low?

The 52-week high is Rs 887.85 and the 52-week low is Rs 485.00. At Rs 802.75, YATHARTH is positioned within this range as detailed in this Yatharth Hospital and Trauma Care Services analyst review.

What are the key risks for Yatharth Hospital and Trauma Care Services?

Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the Healthcare – Hospitals sector, all assessed in this Yatharth Hospital and Trauma Care Services analyst review.

Where can I track live data for Yatharth Hospital and Trauma Care Services?

Track Yatharth Hospital and Trauma Care Services’s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this Yatharth Hospital and Trauma Care Services analyst review.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply